Advertisement
NeuroScientistNews
NeuroScientistNews

The Scientist

» biotech

Most Recent

image: Sanofi Thief Reprimanded

Sanofi Thief Reprimanded

By | May 8, 2012

A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.

0 Comments

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Self-prescribing Patients?

Self-prescribing Patients?

By | March 13, 2012

The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.

4 Comments

image: Opinion: On the Gene Patent Debate

Opinion: On the Gene Patent Debate

By | March 7, 2012

Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?

18 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

image: Female Frontrunners

Female Frontrunners

By | February 1, 2012

How to successfully surmount the challenges women face in becoming biotech industry leaders

7 Comments

image: Cornell to Build NYC Research Campus

Cornell to Build NYC Research Campus

By | December 21, 2011

New York City major names Cornell University as the winner of the year-long competition for rights to build a new sci-tech research facility in the city.

9 Comments

image: The Companies that Failed

The Companies that Failed

By | December 20, 2011

A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times

6 Comments

image: Universities Roll-back Pharma’s Fees

Universities Roll-back Pharma’s Fees

By | December 20, 2011

Research universities are removing the licensing fees they charged industry companies for working with their scientists.

15 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
NeuroScientistNews
NeuroScientistNews

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist